BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 10350329)

  • 1. Chromosomal rearrangement of the PAX-5 locus in lymphoplasmacytic lymphoma with t(9;14)(p13;q32).
    Iida S; Rao PH; Ueda R; Chaganti RS; Dalla-Favera R
    Leuk Lymphoma; 1999 Jun; 34(1-2):25-33. PubMed ID: 10350329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The t(9;14)(p13;q32) chromosomal translocation associated with lymphoplasmacytoid lymphoma involves the PAX-5 gene.
    Iida S; Rao PH; Nallasivam P; Hibshoosh H; Butler M; Louie DC; Dyomin V; Ohno H; Chaganti RS; Dalla-Favera R
    Blood; 1996 Dec; 88(11):4110-7. PubMed ID: 8943844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of the PAX5/BSAP transcription factor in haematological tumour cells and further molecular characterization of the t(9;14)(p13;q32) translocation in B-cell non-Hodgkin's lymphoma.
    Hamada T; Yonetani N; Ueda C; Maesako Y; Akasaka H; Akasaka T; Ohno H; Kawakami K; Amakawa R; Okuma M
    Br J Haematol; 1998 Aug; 102(3):691-700. PubMed ID: 9722295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deregulated PAX-5 transcription from a translocated IgH promoter in marginal zone lymphoma.
    Morrison AM; Jäger U; Chott A; Schebesta M; Haas OA; Busslinger M
    Blood; 1998 Nov; 92(10):3865-78. PubMed ID: 9808580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The t(9;14)(p13;q32) translocation in B-cell non-Hodgkin's lymphoma.
    Ohno H; Ueda C; Akasaka T
    Leuk Lymphoma; 2000 Feb; 36(5-6):435-45. PubMed ID: 10784387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. t(9;14)(p13;q32) involving the PAX-5 gene: a unique subtype of 14q32 translocation in B cell non-Hodgkin's lymphoma.
    Amakawa R; Ohno H; Fukuhara S
    Int J Hematol; 1999 Feb; 69(2):65-9. PubMed ID: 10071452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deregulation of PAX-5 by translocation of the Emu enhancer of the IgH locus adjacent to two alternative PAX-5 promoters in a diffuse large-cell lymphoma.
    Busslinger M; Klix N; Pfeffer P; Graninger PG; Kozmik Z
    Proc Natl Acad Sci U S A; 1996 Jun; 93(12):6129-34. PubMed ID: 8650231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-grade B-Cell lymphomas with plasmacytic differentiation lack PAX5 gene rearrangements.
    George TI; Wrede JE; Bangs CD; Cherry AM; Warnke RA; Arber DA
    J Mol Diagn; 2005 Aug; 7(3):346-51. PubMed ID: 16049306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PAX5/IGH rearrangement is a recurrent finding in a subset of aggressive B-NHL with complex chromosomal rearrangements.
    Poppe B; De Paepe P; Michaux L; Dastugue N; Bastard C; Herens C; Moreau E; Cavazzini F; Yigit N; Van Limbergen H; De Paepe A; Praet M; De Wolf-Peeters C; Wlodarska I; Speleman F
    Genes Chromosomes Cancer; 2005 Oct; 44(2):218-23. PubMed ID: 15942942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of PAX5 rearrangements in lymphoplasmacytic lymphomas: reassessing the reported association with t(9;14).
    Cook JR; Aguilera NI; Reshmi-Skarja S; Huang X; Yu Z; Gollin SM; Abbondanzo SL; Swerdlow SH
    Hum Pathol; 2004 Apr; 35(4):447-54. PubMed ID: 15116325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss- and gain-of-function mutations reveal an important role of BSAP (Pax-5) at the start and end of B cell differentiation.
    Morrison AM; Nutt SL; Thévenin C; Rolink A; Busslinger M
    Semin Immunol; 1998 Apr; 10(2):133-42. PubMed ID: 9618759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro Epstein-Barr virus-immortalized lymphoma cell line carrying t(9;14)(p13;q32) chromosome abnormality, derived from splenic lymphoma with villous lymphocytes.
    Daibata M; Taguchi T; Nemoto Y; Iwasaki S; Ohtsuki Y; Taguchi H
    Int J Cancer; 2006 Jan; 118(2):513-7. PubMed ID: 16049984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diffuse large B-cell lymphoma carrying t(9;14)(p13;q32)/PAX5-immunoglobulin heavy chain gene is characterized by nuclear positivity of MUM1 and PAX5 by immunohistochemistry.
    Ohno H; Nakagawa M; Kishimori C; Fukutsuka K; Maekawa F; Takeoka K; Hayashida M; Sakamoto S; Akasaka T; Honjo G
    Hematol Oncol; 2020 Apr; 38(2):171-180. PubMed ID: 31955451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncogenic role of Pax5 in the T-lymphoid lineage upon ectopic expression from the immunoglobulin heavy-chain locus.
    Souabni A; Jochum W; Busslinger M
    Blood; 2007 Jan; 109(1):281-9. PubMed ID: 16968900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcription factor B-cell-specific activator protein (BSAP) is differentially expressed in B cells and in subsets of B-cell lymphomas.
    Krenacs L; Himmelmann AW; Quintanilla-Martinez L; Fest T; Riva A; Wellmann A; Bagdi E; Kehrl JH; Jaffe ES; Raffeld M
    Blood; 1998 Aug; 92(4):1308-16. PubMed ID: 9694719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mapping of MYC breakpoints in 8q24 rearrangements involving non-immunoglobulin partners in B-cell lymphomas.
    Bertrand P; Bastard C; Maingonnat C; Jardin F; Maisonneuve C; Courel MN; Ruminy P; Picquenot JM; Tilly H
    Leukemia; 2007 Mar; 21(3):515-23. PubMed ID: 17230227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Herpes virus type 8-negative primary effusion lymphoma associated with PAX-5 gene rearrangement and hepatitis C virus: a case report and review of the literature.
    Ichinohasama R; Miura I; Kobayashi N; Saitoh Y; DeCoteau JF; Saiki Y; Mori S; Kadin ME; Ooya K
    Am J Surg Pathol; 1998 Dec; 22(12):1528-37. PubMed ID: 9850179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A case of primary splenic large cell lymphoma with a t(9;14)(p13;q32).
    Kawakami K; Amakawa R; Miyanishi S; Okumura A; Hayashi T; Kurata M; Ohno H; Ohno Y; Fukuhara S
    Int J Hematol; 1998 Feb; 67(2):191-8. PubMed ID: 9631587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel five-way translocation, t(3;9;13;8;14)(q27;p13;q32;q24;q32), with concurrent MYC and BCL6 rearrangements in a primary bone marrow B-cell lymphoma.
    Yamamoto K; Matsuoka H; Yakushijin K; Funakoshi Y; Okamura A; Hayashi Y; Minami H
    Cancer Genet; 2011 Sep; 204(9):501-6. PubMed ID: 22018272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of IGH rearrangements in non-Hodgkin's B-cell lymphomas by fluorescence in situ hybridization.
    Bernicot I; Douet-Guilbert N; Le Bris MJ; Morice P; Abgrall JF; Berthou C; Morel F; De Braekeleer M
    Anticancer Res; 2005; 25(5):3179-82. PubMed ID: 16101124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.